Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG).
Dirk-Jan van BeekSjoerd NellCarolina R C PietermanWouter W de HerderAnnenienke C van de VenOlaf M DekkersAnouk N van der Horst-SchriversMadeleine L DrentPeter H BisschopBas HavekesInne H M Borel RinkesMenno R VriensGerlof D ValkPublished in: Journal of surgical oncology (2019)
Life expectancy of patients with MEN1 gastrinoma is reduced. FSG levels and pancreatic NETs ≥2 cm are prognostic factors. FSG levels might guide surveillance intensity, step-up to additional diagnostics, or provide arguments in selecting patients who might benefit from surgery.